Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future

Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the pleural surface associated with asbestos exposure. The median survival of MPM patients is a mere 8–14 months, and there are few biomarkers and no cure available. It is hoped that, eventually, the incidence of MPM will drop and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolini, Fabio, Bocchini, Martine, Bronte, Giuseppe, Delmonte, Angelo, Guidoboni, Massimo, Crinò, Lucio, Mazza, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992646/
https://www.ncbi.nlm.nih.gov/pubmed/32039010
http://dx.doi.org/10.3389/fonc.2019.01519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992646/
https://www.ncbi.nlm.nih.gov/pubmed/32039010
http://dx.doi.org/10.3389/fonc.2019.01519

Ejemplares similares